Please Note: This trial is no longer enrolling new participants
A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-103, a Novel Formulation of UGN-102, for the Treatment of Patients With Low Grade (LG) Nonmuscle Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence (UTOPIA)
Protocol No. | CTO-BL013 | Scope | National |
---|---|---|---|
Principal Investigator | Hristos Kaimakliotis | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |